2017-03-20,TG Therapeutics, Inc. Announces Preclinical Data Presentation At The 2017 American Association For Cancer Research (AACR) Annual Meeting
2017-03-17,TG Therapeutics, Inc. To Present At The 27th Annual Oppenheimer Healthcare Conference
2017-03-13,TG Therapeutics, Inc. To Present At The 29th Annual ROTH Conference
2017-03-10,Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps
2017-03-10,TG Therapeutics, Inc. Announces Fourth Quarter And Year-End 2016 Financial Results And Business Update
2017-03-09,TG Therapeutics, Inc. To Host Conference Call On Fourth Quarter And Year-End 2016 Financial Results And Business Update
2017-03-09,TG Therapeutics, Inc. Announces Pricing Of $50 Million Public Offering Of Common Stock
2017-03-08,TG Therapeutics Announces Proposed Public Offering Of Common Stock
2017-03-08,The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
2017-03-08,Could These 9 Drugs Gain FDA Approval in the Age of Trump?
2017-03-08,The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
2017-03-08,Treehouse Foods, Arconic, Kinder Morgan, Chesapeake Energy: 'Mad Money' Lightning Round
2017-03-08,Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)
2017-03-07,DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Investors It Has Filed A Class Action Lawsuit Against TG Therapeutics, Inc. And Announces A Lead Plaintiff Deadline Of March 7, 2017 - TGTX
2017-03-06,How to Trade Monday's Most Active Stocks - Snap, GM, TG Therapeutics and More
2017-03-06,Notable Monday Option Activity: TGTX, OMED, KMB
2017-03-06,TG Therapeutics Announces Positive Topline Data From Phase 3 GENUINE Study Of TG-1101 In Combination With Ibrutinib In Patients With High Risk Chronic Lymphocytic Leukemia (CLL)
2017-03-03,TG Therapeutics, Inc. Announces Data Presentation At The Upcoming American Academy Of Neurology 69th Annual Meeting
2017-02-27,DEADLINE ALERT: Brower Piven Reminds Investors Of The March 7, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess Of $100,000 From Investment In TG Therapeutics, Inc. To Contact The Firm
2017-02-21,INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors It Has Filed A Class Action Lawsuit Against TG Therapeutics, Inc. And Announces A Lead Plaintiff Deadline Of March 7, 2017
2017-02-21,TG Therapeutics, Inc. Announces Publication of Clinical Data From The Phase 1/2 Trial Of TG-1101 (ublituximab) Monotherapy In The British Journal Of Haematology
2017-02-16,URGENT: Monteverde & Associates PC Encourages TG Therapeutics, Inc. Shareholders With Losses To Contact The Firm Immediately - TGTX
2017-02-15,TGTX SHAREHOLDER REMINDER: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving TG Therapeutics, Inc. And A Lead Plaintiff Deadline Of March 7, 2017
2017-02-14,Bragar Eagel & Squire, P.C. Reminds Investors That A Class Action Lawsuit Has Been Filed Against TG Therapeutics, Inc. (TGTX) And Encourages Investors With Losses To Contact The Firm
2017-02-10,TGTX UPCOMING DEADLINE: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving TG Therapeutics, Inc. And A Lead Plaintiff Deadline Of March 7, 2017
2017-02-09,TG Therapeutics, Inc. To Present At The 2017 BIO CEO & Investor Conference
2017-02-06,Bragar Eagel & Squire, P.C. Announces That A Class Action Lawsuit Has Been Filed Against TG Therapeutics, Inc. (TGTX) And Encourages Investors To Contact The Firm
2017-02-06,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors It Has Filed A Class Action Lawsuit Against TG Therapeutics, Inc. And Announces A Lead Plaintiff Deadline Of March 7, 2017
2017-02-03,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In TG Therapeutics, Inc. Of Class Action Lawsuit And Upcoming Deadline - TGTX
2017-02-01,TGTX SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving TG Therapeutics, Inc. And A Lead Plaintiff Deadline Of March 7, 2017
2017-01-30,SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In TG Therapeutics, Inc. To Contact The Firm Before Lead Plaintiff Deadline
2017-01-24,TG Therapeutics Enters Oversold Territory (TGTX)
2017-01-24,TG Therapeutics Announces Orphan Drug Designation For The Combination Of TG-1101 And TGR-1202 For The Treatment Of Diffuse Large B-cell Lymphoma
2017-01-17,INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In TG Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
2017-01-12,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against TG Therapeutics, Inc. (TGTX) And Lead Plaintiff Deadline: March 13, 2017
2017-01-11,TG Therapeutics Announces Completion Of Enrollment And B-cell Depletion Data From Part 1 Of Ongoing Phase 2 Multiple Sclerosis Study
2017-01-09,TG Therapeutics Announces Orphan Drug Designation For The Combination Of TG-1101 And TGR-1202 For Treatment Of Chronic Lymphocytic Leukemia
2017-01-09,TG Therapeutics, Inc. To Present At The 35th Annual J.P. Morgan Healthcare Conference
2017-01-04,TG Therapeutics, Inc. Announces Investigator Initiated Trial At The University Of Nebraska Medical Center To Study TGR-1202 In Combination With Ibrutinib In Patients With Relapsed Or Refractory Diffuse Large B-cell Lymphoma
2016-12-20,First Week of August 2017 Options Trading For TG Therapeutics (TGTX)
2016-12-16,TG Therapeutics, Inc. Announces Publication Of Clinical Data From The Phase 2 Trial Of TG-1101 (ublituximab) In Combination With Ibrutinib In The British Journal Of Haematology
2016-12-06,TG Therapeutics, Inc. Announces Double & Triple Combination Therapy Data Presentations At The 58th American Society Of Hematology Annual Meeting
2016-12-06,TG Therapeutics, Inc. Announces That The GENUINE Phase 3 Study Has Reached Target Enrollment
2016-12-05,TG Therapeutics, Inc. Announces Oral Data Presentation For TGR-1202 In Combination With Ibrutinib In Patients With Relapsed Or Refractory CLL Or MCL At The 58th American Society Of Hematology Annual Meeting
2016-12-05,TG Therapeutics, Inc. Announces Preclinical Data Presentations For TGR-1202 At The 58th American Society Of Hematology Annual Meeting
2016-12-02,TG Therapeutics, Inc. Recaps Schedule Of Data Presentations At The 58th American Society Of Hematology Annual Meeting
2016-11-23,First Week of January 2017 Options Trading For TG Therapeutics (TGTX)
2016-11-22,TG Therapeutics Announces Positive DSMB Recommendation For Continuation Of The UNITY-CLL Phase 3 Trial
2016-11-07,TG Therapeutics, Inc. Provides Business Update And Reports Third Quarter 2016 Financial Results
2016-11-03,TG Therapeutics, Inc. To Host Conference Call On Third Quarter 2016 Financial Results And Business Update
2016-11-03,TG Therapeutics, Inc. Announces Data Presentations At The Upcoming 58th American Society Of Hematology Annual Meeting
2016-10-31,Lifshitz & Miller Law Firm Announces Investigation Of Electronics For Imaging, Inc., Ferrellgas Partners LP, Fusion Pharm, Inc., Humana Inc., KemPharm, Inc., National Beverage Corp., Puma Biotechnology, Inc., And TG Therapeutics, Inc.
2016-10-31,Interesting TGTX Put And Call Options For December 16th
2016-10-27,TG Therapeutics, Inc. Announces Publication in Blood Describing A Novel Complimentary Mechanism Of The PI3K-delta Inhibitor, TGR-1202
2016-10-20,TG Therapeutics, Inc. Announces The Launch Of The Phase 1/2 Study Of TGR-1202 And Carfilzomib In Patients With Relapsed Or Refractory Lymphoma
2016-10-19,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces An Investigation Of TG Therapeutics, Inc. And Advises Investors With Losses To Contact The Firm
2016-10-19,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of TG Therapeutics, Inc. (TGTX)
2016-10-14,INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of TG Therapeutics, Inc. And Advises Investors With Losses To Contact The Firm
2016-10-14,INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud Violations By TG Therapeutics, Inc. And Certain Officers And Directors
2016-10-13,TG Therapeutics (TGTX) Stock Slumps on Trial Amendment
2016-10-13,Pardon Me, but I Have a Few Things to Say... Seattle Genetics, Biomarin, Sarepta, TG Therapeutics
2016-10-13,TG Therapeutics, Inc. Amends The GENUINE Phase 3 Clinical Trial To Accelerate Study Completion By Revising Primary Endpoint To Overall Response Rate
2016-10-12,TG Therapeutics, Inc. To Host Conference Call To Provide An Update On The GENUINE Phase 3 Trial
2016-10-03,Commit To Buy TG Therapeutics At $7.50, Earn 29.9% Annualized Using Options
2016-09-23,TG Therapeutics, Inc. To Present At The Ladenburg Thalmann 2016 Healthcare Conference
2016-09-16,TG Therapeutics, Inc. Announces Presentation Of Data From A Phase Ib Clinical Trial Of TG-1101 In Patients With Neuromyelitis Optica (NMO) At The 32nd Congress Of The European Committee For Treatment And Research In Multiple Sclerosis
2016-08-31,TG Therapeutics, Inc. Announces Clinical Data Presentation At The Upcoming 32nd Congress Of The European Committee For Treatment And Research In Multiple Sclerosis
2016-08-30,2 Biotechs to Watch Ahead of the Election
2016-08-26,TG Therapeutics Announces Orphan Drug Designation For TG-1101 For The Treatment Of Neuromyelitis Optica And Neuromyelitis Optica Spectrum Disorder
2016-08-24,TG Therapeutics Announces Orphan Drug Designation For TGR-1202 For Treatment Of Chronic Lymphocytic Leukemia
2016-08-12,TG Therapeutics Looks Like a Healthy Play
2016-08-08,TG Therapeutics, Inc. Announces Second Quarter 2016 Financial Results And Business Update
2016-08-04,TG Therapeutics, Inc. To Host Conference Call On Second Quarter 2016 Financial Results And Business Update
2016-07-19,Relative Strength Alert For TG Therapeutics
2016-06-22,First Week of TGTX February 2017 Options Trading
2016-06-10,TG Therapeutics, Inc. Announces Data From TGR-1202 In Combination With Ibrutinib As Well As Recaps Long-Term Safety And Efficacy Data Of TGR-1202 In CLL And NHL At The 21st European Hematology Association Annual Congress
2016-06-09,TG Therapeutics, Inc. To Present At The Jefferies 2016 Healthcare Conference
2016-06-07,Weak On High Volume: TG Therapeutics (TGTX)
2016-06-07,5 Small-Cap Favorites Are Moving on Up
2016-06-07,TG Therapeutics, Inc. Announces First Patient Enrolled In The Registration-Directed UNITY-DLBCL Phase 2b Trial
2016-06-06,TG Therapeutics, Inc. Announces Long-Term Follow-up Of TGR-1202 Demonstrates A Differentiated Safety Profile And High Response Rates In CLL And NHL In Data Presented At The 52nd Annual Meeting Of The American Society Of Clinical Oncology
2016-06-02,TG Therapeutics, Inc. Recaps Schedule Of Clinical Data Presentations At The 52nd Annual Meeting Of The American Society Of Clinical Oncology
2016-05-27,TG Therapeutics Enters Into A Global Collaboration To Develop And Commercialize Novel BET Inhibitors Developed By Jubilant Biosys For The Treatment Of Hematological Malignancies
2016-05-20,TG Therapeutics, Inc. Announces Clinical Data Presentations At The Upcoming 21st European Hematology Association Annual Congress
2016-05-18,TG Therapeutics, Inc. Announces Clinical Data Presentation At The Upcoming 52nd Annual Meeting Of The American Society Of Clinical Oncology
2016-05-12,RSI Alert: TG Therapeutics (TGTX) Now Oversold
2016-05-12,Profiting on Small-Cap Biotech Earnings
2016-05-10,TG Therapeutics, Inc. Announces First Quarter 2016 Financial Results And Business Update
2016-05-09,TG Therapeutics, Inc. To Host Conference Call On First Quarter 2016 Financial Results And Business Update
2016-05-03,TG Therapeutics, Inc. Launches First Clinical Trial In Multiple Sclerosis (MS) For TG-1101 (Ublituximab)
2016-04-27,'Mad Money' Lightning Round: Get Ready to Buy Palo Alto Networks
2016-04-26,Jim Cramer's 'Mad Money' Recap: Stay Positive, Stay Focused, Ignore Apple
2016-04-22,Commit To Purchase TG Therapeutics At $7.50, Earn 16.2% Annualized Using Options
2016-04-21,Insider Trading Alert - BLOX, ILMN And TGTX Traded By Insiders
2016-04-18,TG Therapeutics, Inc. Announces Pre-Clinical Data Presentation On TGR-1202 Demonstrating Differentiated Effects On T-Cells
2016-04-13,TG Therapeutics, Inc. Announces Issuance Of Composition Of Matter Patent For TG-1101 In The United States
2016-03-30,7 Stocks Under $10 to Trade for Breakout Gains
2016-03-17,TG Therapeutics, Inc. Announces Pre-Clinical Data Presentation On TGR-1202 At The 2016 American Association For Cancer Research (AACR) Annual Meeting
2016-03-11,TG Therapeutics, Inc. To Present At The 28th Annual ROTH Conference
2016-03-07,TG Therapeutics, Inc. Announces Fourth Quarter And Year-End 2015 Financial Results And Business Update
2016-03-07,TG Therapeutics, Inc. To Present At Upcoming Investment Conferences
2016-03-04,TG Therapeutics, Inc. To Host Conference Call On Fourth Quarter And Year-End 2015 Financial Results And Business Update
2016-02-23,TG Therapeutics, Inc. Announces Issuance Of Composition Of Matter Patent For TGR-1202 In The United States
2016-02-03,TG Therapeutics, Inc. To Present At The 18th Annual BIO CEO & Investor Conference
2016-01-29,8 Stocks Under $10 Making Big Moves Higher
2016-01-26,TG Therapeutics (TGTX) Highlighted As Weak On High Volume
2016-01-22,First Week of TGTX March 18th Options Trading
2016-01-19,TG Therapeutics, Inc. Sets Corporate Goals And Objectives For 2016
2016-01-12,TG Therapeutics (TGTX) Is Strong On High Volume Today
2016-01-11,TG Therapeutics, Inc. To Present At The 34th Annual J.P. Morgan Healthcare Conference
2016-01-07,TG Therapeutics is Now Oversold (TGTX)
2015-12-07,TG Therapeutics, Inc. Announces Oral Presentation Of Novel Pre-Clinical Combinations With TGR-1202 By Investigators At Columbia University At The 57th American Society Of Hematology Annual Meeting
2015-12-07,TG Therapeutics, Inc. Announces Data Presentations For TGR-1202 And TG-1101 In Combination With Ibrutinib At The 57th American Society Of Hematology Annual Meeting
2015-12-06,TG Therapeutics, Inc. Announces Data Presentations At The 57th American Society Of Hematology Annual Meeting From Ongoing Clinical Studies In Patients With Non-Hodgkins Lymphoma (NHL) And Chronic Lymphocytic Leukemia (CLL)
2015-12-04,TG Therapeutics, Inc. Recaps Schedule Of Data Presentations At The 57th American Society Of Hematology Annual Meeting
2015-12-01,Trade-Ideas: TG Therapeutics (TGTX) Is Today's Strong On High Relative Volume Stock
2015-11-09,TG Therapeutics, Inc. Announces Third Quarter 2015 Financial Results And Business Update
2015-11-05,TG Therapeutics, Inc. Announces Data Presentations At The Upcoming 57th American Society Of Hematology Annual Meeting
2015-11-04,TG Therapeutics, Inc. To Host Conference Call On Third Quarter 2015 Financial Results And Business Update
2015-10-06,Jim Cramer's Top Takeaways: TG Therapeutics, Mallinckrodt, General Electric
2015-10-05,Jim Cramer's 'Mad Money' Recap: Here's Where the Bear Tide Is Turning
2015-10-05,4 Unusual-Volume Stocks to Trade for Breakouts
2015-09-25,TG Therapeutics, Inc. To Present At The Ladenburg Thalmann 2015 Healthcare Conference
2015-09-17,TG Therapeutics (TGTX) Is Strong On High Volume Today
2015-09-17,TG Therapeutics Announces Special Protocol Assessment (SPA) Agreement With The FDA For The First Phase 3 Clinical Trial Of Its Proprietary Combination Regimen Of TG-1101 (ublituximab) In Combination With TGR-1202 For Patients With Chronic Lymphocytic Leukemia (CLL)
2015-09-10,Strong On High Relative Volume: TG Therapeutics (TGTX)
2015-09-09,TG Therapeutics, Inc. Launches Phase 1/2 "Triple-Therapy" Study With TGR-1202 + TG-1101 + The PD-1 Checkpoint Inhibitor Pembrolizumab In Patients With Advanced Chronic Lymphocytic Leukemia (CLL) At The University Of Pennsylvania's Abramson Cancer Center
2015-09-08,TG Therapeutics, Inc. To Participate In Upcoming Investment Conferences In September
2015-08-28,First Week Of TGTX October 16th Options Trading
2015-08-21,Relative Strength Alert For TG Therapeutics
2015-08-10,TG Therapeutics, Inc. Announces Second Quarter 2015 Financial Results And Business Update
2015-08-05,TG Therapeutics, Inc. To Host Conference Call On Second Quarter 2015 Financial Results And Business Update
2015-07-03,Insider Trading Alert - PRAA, KIRK And TGTX Traded By Insiders
2015-06-23,Interesting TGTX Put And Call Options For February 2016
2015-06-22,TG Therapeutics (TGTX) Is Strong On High Volume Today
2015-06-18,Updated Results From Phase 2 Clinical Trial Of TG-1101 (Ublituximab) In Combination With Ibrutinib Confirms Robust Clinical Activity With A Favorable Safety Profile In Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL)
2015-06-11,TG Therapeutics To Present Clinical Data On TG-1101 And TGR-1202 At The 20th Congress Of The European Hematology Association And The 13th International Congress On Malignant Lymphoma
2015-06-10,'Mad Money' Lightning Round: Wells Fargo Is World's Best Financial
2015-06-09,Jim Cramer's 'Mad Money' Recap: Why You Need Common Sense in This Market
2015-06-02,TG Therapeutics, Inc. To Present At The Jefferies 2015 Healthcare Conference
2015-06-01,TG Therapeutics Announces The Triple Combination Of TG-1101, TGR-1202 And Ibrutinib Is Safe And Highly Active In Patients With Advanced B-Cell Malignancies
2015-05-31,TG Therapeutics, Inc. Announces Presentations Of Its Proprietary Combination Of TG-1101 Plus TGR-1202 As Well As TGR-1202 As A Single Agent In Ongoing Phase I/Ib Dose Escalation Clinical Studies
2015-05-29,TG Therapeutics, Inc. Recaps Schedule Of Clinical Data Presentations At The 51st Annual Meeting Of The American Society Of Clinical Oncology
2015-05-13,TG Therapeutics, Inc. Announces Clinical Data Presentations At The Upcoming 51st Annual Meeting Of The American Society Of Clinical Oncology
2015-05-11,The US Stock Market's Mood Shift
2015-05-05,TG Therapeutics Enters Oversold Territory (TGTX)
2015-05-04,TG Therapeutics, Inc. Announces First Quarter 2015 Financial Results And Business Update
2015-05-02,'Mad Money' Lightning Round: Buy Blackstone and MasterCard
2015-05-01,Jim Cramer's 'Mad Money' Recap: Warren Buffett Is Part of Next Week's Game Plan
2015-05-01,TG Therapeutics, Inc. To Present At The Deutsche Bank 40th Annual Health Care Conference
2015-04-30,TG Therapeutics, Inc. To Host Conference Call On First Quarter 2015 Financial Results And Business Update
2015-04-28,First Week Of TGTX June 19th Options Trading
2015-04-20,TG Therapeutics, Inc. Presents Pre-clinical Data On IRAK4 Compounds At The American Association For Cancer Research (AACR) Annual Meeting
2015-04-14,'Mad Money' Lightning Round: I Like Phillips 66, Don't Sell It
2015-04-13,Jim Cramer's 'Mad Money' Recap: Don't Leave Gains on the Table
2015-03-25,First Week Of November 20th Options Trading For TG Therapeutics (TGTX)
2015-03-23,Today's Weak On High Volume Stock: TG Therapeutics (TGTX)
2015-03-20,TG Therapeutics (TGTX) Showing Signs Of Perilous Reversal Today
2015-03-18,'Mad Money' Lightning Round: I Don't Like Caterpillar, Buy TG Therapeutics
2015-03-17,Jim Cramer's 'Mad Money' Recap: This Maddening Market Can't Make Up Its Mind
2015-03-13,Trade-Ideas: TG Therapeutics (TGTX) Is Today's Strong On High Relative Volume Stock
2015-03-11,TG Therapeutics, Inc. Announces Fourth Quarter And Year-End 2014 Financial Results And Business Update
2015-03-11,Short Interest In TG Therapeutics Moves 16.7% Lower
2015-03-10,TG Therapeutics, Inc. To Host Conference Call On Fourth Quarter And Year-End 2014 Financial Results And Business Update
2015-03-06,TG Therapeutics, Inc. To Present At The 27th Annual ROTH Conference
2015-03-04,TG Therapeutics Enters Into A Global Collaboration With Checkpoint Therapeutics To Develop And Commercialize Novel Immuno-Oncology Targeted Antibodies
2015-03-02,TG Therapeutics, Inc. To Present At The Cowen And Company 35th Annual Health Care Conference
2015-02-27,FireEye, 3 More Are Hot Momentum Stocks Despite Overheated Market
2015-02-06,'Mad Money' Lightning Round: Buy, Buy, Buy GlaxoSmithKline and Box
2015-02-05,Jim Cramer's 'Mad Money' Recap: Cheap Stocks Aren't Bad Stocks
2015-02-04,TG Therapeutics, Inc. To Present At The 17th Annual BIO CEO & Investor Conference
2015-01-24,McDonald's and UPS Deserve Better; Bob Dylan Was Right: Jim Cramer's Best Blogs
2015-01-23,First Week Of March 20th Options Trading For TG Therapeutics (TGTX)
2015-01-22,Jim Cramer's Top Stock Picks: NFLX FOLD TGTX
2015-01-15,TG Therapeutics, Inc. To Provide An Update On Its Clinical Programs And Corporate Goals For 2015 At The 33rd Annual J.P. Morgan Healthcare Conference
2015-01-08,TG Therapeutics, Inc. To Present At The 33rd Annual J.P. Morgan Healthcare Conference
2015-01-06,Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains
2015-01-06,Interesting TGTX Put And Call Options For August 21st
2014-12-29,Commit To Buy TG Therapeutics At $15, Earn 31.1% Annualized Using Options
2014-12-17,TG Therapeutics, Inc. Announces Appointment Of Kenneth Hoberman To Board Of Directors
